Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of cell-derived versus egg-derived trivalent subunit influenza vaccine in healthy adults
2005-002257-47Phase 3Completed
- Sponsor
- Chiron Corporation
- Start
- Jun 2005
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of influenza vaccine, inactivated, surface antigen in influenza (4 arms), sponsored by Chiron Corporation. Primary endpoints: Safety and tolerability and Immunogenicity by hemagglutination inhibition. Started Jun 2005; status: completed.
02
Drugs
influenza vaccine, inactivated, surface antigen
03
Conditions
influenza
Beyond the preview
Go deeper on 2005-002257-47.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002257-47.